We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£151.20
About as cheap as it gets — within 5% of the all-time low it hit 2 months ago.
£151 today · all-time low £151 (Aug 2026) · usually the usual
Springer Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology)
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 56 days · 56 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 56 days • 2 price levels
Price Analysis
Most common price: £152 (30 days, 53.6%)
Price range: £151 - £152
Price levels: 2 different prices over 56 days
Description
Product Specifications
- Brand
- Springer
- Format
- paperback
- ASIN
- 1475709730
- Domain
- Amazon UK
- Publication Date
- 26 November 2012
- Listed Since
- 14 July 2013
Barcode
No barcode data available
Similar Products You Might Like
Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology, 51)
Springer
Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)
Springer
Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)
Springer
Neurobiology of DOPA as a Neurotransmitter
CRC Press
Catecholamines II: 90 / 2 (Handbook of Experimental Pharmacology, 90 / 2)
Springer
Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)
Humana
Progress in Alzheimer’s and Parkinson’s Diseases: 49 (Advances in Behavioral Biology, 49)
Springer
Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects: 37 (Polymer Science and Technology Series, 37)
Humana
Control of Gene Expression by Catecholamines and the Renin-Angiotensin System: 33 (Developments in Molecular and Cellular Biochemistry, 33)
Springer
Catecholamines and the Heart: Recent Advances in Experimental and Clinical Research
Springer
Monoamine Oxidase Inhibitors: Clinical Pharmacology, Benefits, & Potential Health Risks
Parkinson’s Disease―II: Aging and Neuroendocrine Relationships: 113 (Advances in Experimental Medicine and Biology, 113)
Springer
Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)
Humana
Panel Discussions: Third World Congress of Anaesthesiology São Paulo, Brazil · September 1964: 8 (Anaesthesiology and Resuscitation, 8)
Springer
Biochemistry & Histocytochemistry Research Developments (Biochemistry Research Trends Series)
Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)
Springer
Horizons in Neuroscience Research: Volume 37
Alzheimer’s and Parkinson’s Diseases: Recent Developments: 44 (Advances in Behavioral Biology, 44)
Springer
Excitotoxins: Proceedings of an International Symposium held at The Wenner-Gren Center, Stockholm, August 26–27, 1982: 39 (Wenner-Gren Center International Symposium Series)
Springer
Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment
Springer
Alzheimer’s and Parkinson’s Diseases: Recent Developments: 44 (Advances in Behavioral Biology, 44)
Springer
Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models
Elsevier
The Adenosinergic System: A Non-Dopaminergic Target in Parkinson’s Disease: 10 (Current Topics in Neurotoxicity)
Springer
Chemical Biology of Neurodegeneration: Molecular Approach
Wiley